Proposed mandate for instructions and labeling regarding the use of eye drops.
Flach
Allan J
AJ
Department of Ophthalmology, University of California-San Francisco Medical Center, San Francisco, CA 94143, USA. allan.flach@med.va.gov
D000287:Administration, Topical; D001682:Biological Availability; D001767:Blinking; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D005143:Eyelids / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007767:Lacrimal Duct Obstruction / Q000378:metabolism; D009883:Ophthalmic Solutions / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010349:Patient Compliance; D010353:Patient Education as Topic; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D009883:Ophthalmic Solutions